Form 4: Amedisys Inc. Executive Nick Muscato Reports Stock Transaction

Nick Muscato, Chief Strategy Officer of Amedisys Inc., reports the disposition of shares to cover tax obligations.

Summary

• On July 25, 2024, Nick Muscato, Chief Strategy Officer of Amedisys Inc., reported a transaction involving common stock.
• A total of 108 shares were disposed of at a price of $97.75 per share to cover tax obligations.
• Following the transaction, Muscato directly owns 20,408 shares of common stock.
• Muscato also indirectly owns 212 shares through a 401(k) plan, based on a plan statement dated June 30, 2024.

Sentiment

Score: 5

Explanation: The document is a routine regulatory filing detailing a stock transaction. It doesn't inherently convey positive or negative sentiment.

Industry Context

This filing is a routine disclosure of stock transactions by a company executive, which is a common practice in publicly traded companies. It provides transparency to investors regarding insider activity.

Comparison to Industry Standards

• Form 4 filings are standard practice for publicly traded companies, ensuring transparency regarding insider transactions.
• Similar filings are made by executives at companies like UnitedHealth Group (UNH) and CVS Health (CVS) when they engage in stock transactions.
• The level of detail provided in this Form 4 is consistent with regulatory requirements and industry norms.

Stakeholder Impact

• The transaction is unlikely to have a significant impact on shareholders, as it is a small percentage of the total outstanding shares.

Key Dates